I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient ...
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback